Can-Fite BioPharma (NYSE:CANF) Earns Sell Rating from Analysts at StockNews.com

Retrieved on: 2022-11-13 08:33:29

Tags for this article:

Click the tags to see associated articles and topics

Can-Fite BioPharma (NYSE:CANF) Earns Sell Rating from Analysts at StockNews.com. View article details on HISWAI: https://www.etfdailynews.com/2022/11/13/can-fite-biopharma-nysecanf-earns-sell-rating-from-analysts-at-stocknews-com/

Excerpt

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver ...

Article found on: www.etfdailynews.com

View Original Article